• GLG-ESCMID AMR Meeting

    hybrid Lisbon, Portugal

    ESCMID and the Global Leaders Group on Antimicrobial Resistance will co-host a high-level symposia/conference free of charge on 14 April 2023, 15:00 -18:30 CEST, with the aim of strengthening the links between research, policy, and practice in order to develop sustainable solutions and a broader AMR research agenda. World leaders, policy makers, the private sector, civil society […]

  • IMI impact on early career researchers

    Online

    This online event will showcase how working in public-private partnerships like IMI projects can boost the professional development of early career researchers. More information here.

  • UNITE4TB Symposium 2023

    Hotel Van der Valk, Nijmegen - Lent

    Click here for more information.

  • ESPID 2023

    hybrid Lisbon, Portugal

    You are invited to the 41st Annual Meeting of the European Society for Paediatric Infectious Diseases in Lisbon & Online, 8-12 May 2023. Join researchers and specialists from Europe and around the world, who are dedicated to researching, treating and preventing infectious diseases in children. Find out more and register here.

  • Population Approach Group Europe: PAGE 2023

    A Coruña, Spain A Coruña, Spain

    PAGE represents a community with a shared interest in data analysis using the population approach. It is a not-for-profit organisation (company limited by guarantee) with registered office in England and Wales. A meeting is held in June each year at a different European location. PAGE 2023 will take place over a period of four days between 27 June to 30 […]

  • The Tuberculosis Drug Discovery and Development GRC

    Rey Don Jaime Grand Hotel Avinguda de l'Hotel | 22 Castelldefels, Castelldefels, Spain

    The ERA4TB project will host a session on lysyl transfer RNA synthetase as a novel drug target for tuberculosis. In addition, their scientific leader, Stewart Cole, Institut Pasteur will provide a keynote in the session "Applying New Technologies and Recent Learnings From TB Drug Discovery and Development, Towards Next Generation Treatments." Find out more here.